Epo-R / TRP channels
Name: Erythropoietin receptor
(Epo-R)
Official Symbol: EPOR
provided by HGNC
Function:
Receptor for erythropoietin. Mediates erythropoietin-induced erythroblast proliferation and differentiation. Upon EPO stimulation, EPOR dimerizes triggering the JAK2/STAT5 signaling cascade. In some cell types, can also activate STAT1 and STAT3. May also activate the LYN tyrosine kinase.Isoform EPOR-T acts as a dominant-negative receptor of EPOR-mediated signaling.
Source: Reorganizing the protein space at the Universal Protein Resource (UniProt)
Nucleic Acids Res. 40: D71-D75 (2012).
Species | External DB | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Entrez Gene | UniprotKB | DIP | IntAct | MINT | BioGRID | STRING | IUPHAR-DB | KEGG | OMIM | |
Human
|
2057 | P19235 | DIP-5732N | P19235 | MINT-273225 | 108371 | P19235 | hsa:2057 | 133171 | |
Mouse
|
13857 | P14753 | DIP-657N | P14753 | MINT-1348473 | 199488 | P14753 | mmu:13857 | ||
Rat
|
24336 | Q07303 | MINT-4596642 | 246513 | Q07303 | rno:24336 |
Biological Process:
- GO:0007420 : brain development
- GO:0046697 : decidualization
- GO:0007204 : elevation of cytosolic calcium ion concentration
- GO:0009790 : embryo development
- GO:0007507 : heart development
Source: The Gene Ontology Consortium. Gene ontology: tool for the unification of biology. Nat. Genet.. May 2000;25(1):25-9.
World Wide Web URL: http://www.geneontology.org/
World Wide Web URL: http://www.geneontology.org/
Disease:
- OMIM:133171 : Erythrocytosis, familial, 1 (OMIM:133100 )
Source: Online Mendelian Inheritance in Man, OMIM®. McKusick-Nathans Institute of Genetic Medicine,
Johns Hopkins University (Baltimore, MD), May, 2012.
World Wide Web URL: http://omim.org/
World Wide Web URL: http://omim.org/
Screening Validation: In vitro validation Validation: In vivo validation Characterization Functional consequence | top |
Screening | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Experimental screening | Non-experimental screening | Reference | ||||||||
TRP channel construct | Interactor source | |||||||||
TRP channel | Interactor | Method | Species | Region | Species | Organ/tissue | Sample type | |||
TRPC2 | Epo-R | Inference | Prediction | 12167663 | ||||||
TRPC2 | Epo-R | Inference | Prediction | 15329338 | ||||||
TRPC3 | Epo-R | Inference | Prediction | 18276585 | ||||||
TRPC6 | Epo-R | Inference | Prediction | 19074769 |
(:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)
Screening Validation: In vitro validation Validation: In vivo validation Characterization Functional consequence | top |
Validation: In vivo validation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Assay with endogenous proteins | Assay with overexpressed proteins | Reference | ||||||||
Cell or tissue | Cell or tissue | TRP channel construct | Interactor construct | |||||||
TRP channel | Interactor | Method | Species | Region | Species | Region | ||||
TRPC2 | Epo-R | Co-immunofluorescence staining | CHO | Mouse | Full-length | Mouse | Full-length | 12167663 | ||
TRPC2 | Epo-R | Co-immunoprecipitation | CHO-S | Mouse | Full-length | Mouse | Full-length | 15329338 | ||
TRPC2 | Epo-R | Co-immunoprecipitation | Mouse erythroblasts | 15329338 | ||||||
TRPC2 | Epo-R | Co-immunoprecipitation | CHO-S | Mouse | Full-length | Mouse | Full-length | 22088247 | ||
TRPC3 | Epo-R | Co-immunofluorescence staining | HEK293T | Human | Full-length | Human | Full-length | 19074769 | ||
TRPC3 | Epo-R | Co-immunoprecipitation | HEK293T | Human | Full-length | Human | Full-length | 21757714 | ||
TRPC3 | Epo-R | Co-immunoprecipitation | HEK293T | Human | Full-length | Human | Full-length | 18276585 | ||
TRPC3 | Epo-R | Co-immunoprecipitation | HEK293T | Human | Full-length | Human | Full-length | 19074769 | ||
TRPC3 | Epo-R | Co-immunoprecipitation | TF-1 | 19074769 | ||||||
TRPC6 | Epo-R | Co-immunoprecipitation | HEK293T | Human | Full-length | Human | Full-length | 19074769 |
(:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)
Screening Validation: In vitro validation Validation: In vivo validation Characterization Functional consequence | top |
Characterization | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Binding region mapping | Stoichiometry | Affinity (Kd) | Reference | |||||||
TRP channel | Interactor | |||||||||
TRP channel | Interactor | Method | Species | Region | Species | Region | ||||
TRPC3 | Epo-R | Co-immunoprecipitation | Human | 671-746 | Human | Not determined | 19074769 |
(:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)
Screening Validation: In vitro validation Validation: In vivo validation Characterization Functional consequence | top |
Functional consequence | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
TRP channel | Interactor | Method | Post-translational modification | Subcellular trafficking | Activity | Reference | ||||||
TRPC2 | Epo-R | Calcium measurement | Activation | 12167663 | ||||||||
TRPC3 | Epo-R | Calcium measurement | Activation | 18276585 | ||||||||
TRPC3 | Epo-R | Patch clamp | Activation | 18276585 |
(:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)